Document Detail

Long-term work disability in patients with psoriatic arthritis treated with anti-tumour necrosis factor: a population-based regional Swedish cohort study.
MedLine Citation:
PMID:  23148309     Owner:  NLM     Status:  Publisher    
OBJECTIVE: To study long-term work disability before and after tumour necrosis factor (TNF)-antagonist therapy in patients with psoriatic arthritis (PsA). METHODS: Using the population-based South Swedish Arthritis Treatment Group Register, we identified 191 patients with PsA (median age 43 years, range 18-58 years, 54% men), who between January 2003 and December 2007 started treatment with adalimumab, etanercept or infliximab. We linked data to the Swedish Social Insurance Agency and calculated the proportion of work disability in 30-day intervals from 12 months before the start of treatment until 3 years after. For each patient with PsA we randomly selected four matched reference subjects from the general population. RESULTS: At treatment initiation 67% of the patients with PsA were work disabled-that is, either on sick leave (41.5%) or receiving a disability pension (25.3%). Patients sustaining treatment were, on average, work disabled 12.5 days a month at treatment initiation declining to 10.6 days a month after 3 years of treatment. Patients for whom the first treatment course failed were work disabled 16.5 days at treatment start decreasing to 15.6 days after 3 years. The background population were 2.5 days and 3.0 days off work each month, respectively. Regression modelling identified prior work disability status, anti-TNF treatment failure, higher age, female gender and longer disease duration as significant predictors of working disability. CONCLUSIONS: There was a decline in net work disability after initiation of anti-TNF treatment in patients with PsA. Patients withdrawing from treatment had a 50% increased risk of being work disabled. Prior work disability, higher age, female gender and longer disease duration were also associated with long-term work disability.
Lars Erik Kristensen; Martin Englund; Martin Neovius; Johan Askling; Lennart T H Jacobsson; Ingemar F Petersson
Related Documents :
1857569 - Effective hypertension control in inner city blacks.
14646679 - Pooled-data analysis of three randomized, double-masked, six-month studies comparing in...
17470529 - The use of impression cytology in the follow-up of severe ocular burns.
20456259 - Effects of pegaptanib injections on intraocular pressure with and without anterior cham...
17181099 - The role of mitomycin c in surgery of the frontonasal recess: a prospective open pilot ...
2078039 - The combined use of apraclonidine and pilocarpine during laser iridotomy in a hispanic ...
24560249 - "no turn back approach" to reduce treatment time for endovascular treatment of acute is...
21814379 - Carbamzepine-induced toxic epidermal necrolysis.
21669569 - A new scoring system for assessment of liver function after successful hepatectomy in p...
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2012-11-12
Journal Detail:
Title:  Annals of the rheumatic diseases     Volume:  -     ISSN:  1468-2060     ISO Abbreviation:  Ann. Rheum. Dis.     Publication Date:  2012 Nov 
Date Detail:
Created Date:  2012-11-13     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  0372355     Medline TA:  Ann Rheum Dis     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
1Department of Orthopedics, Clinical Sciences Lund, Lund University, Lund, Sweden.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  TLR4 as receptor for HMGB1 induced muscle dysfunction in myositis.
Next Document:  Postnatal depression in mothers bringing infants to the emergency department.